Follow-up advice on conditional inclusion of larotrectinib (Vitrakvi®)
de Vries S, Wijma S
Record ID 32018002686
Dutch
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2021/08/16/follow-up-advice-conditional-inclusion-of-larotrectinib-vitrakvi
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Neoplasms
- Antineoplastic Agents
- Pyrazoles
- Pyrimidines
- Gene Fusion
- Protein Kinase Inhibitors
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.